October 8, 2024
Several artificial intelligence (AI) technologies are emerging that will change the management of gastrointestinal (GI) diseases sooner rather than later. One of the leading researchers working […]
October 4, 2024
The US Food and Drug Administration (FDA) approved Exact Sciences’ next-generation multitarget stool DNA (mt-sDNA) test, Cologuard Plus, for use in adults 45 or older who […]
October 3, 2024
TOPLINE: Physician training in shared decision-making does not increase the proportion of older adults who receive their preferred colorectal cancer (CRC) screening approach, new research suggests. […]
October 2, 2024
The experimental monoclonal antibody tulisokibart safely induced clinical remission in a phase 2 randomized trial of moderately to severely active ulcerative colitis (UC). In one cohort […]
October 1, 2024
Among patients with Crohn’s disease, a multicenter prospective cohort study found that anti-TNF therapy failed to achieve remission at 3 years in about two-thirds of cases, […]
October 1, 2024
TOPLINE: Accounting for racial disparities, including in the quality of family history data, enhanced the predictive performance of a colorectal cancer (CRC) risk prediction model. METHODOLOGY: […]
October 1, 2024
TOPLINE: A unique glycosylation signature on circulating antibodies is detectable in blood up to 6 years before a diagnosis of Crohn’s disease and could serve as […]
September 30, 2024
TOPLINE: A new epigenetic assay is able to stratify patients with Barrett’s esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma […]
September 25, 2024
In a review of 32 mixed-type human studies, multinational researchers found a growing association between various classes of environmental pollutants and the risk for inflammatory bowel […]